EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 23, 2023
Media advisory: The full study is linked to this news release.
Source: JAMA Cardiology
Free access to the full-text article, live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2023.2424?guestAccessKey=c0dd75d6-3fe6-46c4-bab7-44ed4535af9c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082323
About The Study: The results of this study suggest that the majority of fish oil supplement labels make health claims, usually in the form of structure/function claims, that imply a health benefit across a variety of organ systems despite a lack of trial data showing efficacy. Significant heterogeneity exists in the daily dose of eicosapentaenoic acid + docosahexaenoic acid in available supplements, leading to potential variability in safety and efficacy between supplements.
Authors: Ann Marie Navar, M.D., Ph.D., of the University of Texas Southwestern Medical Center in Dallas, is the corresponding author.
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.